fluorodeoxyglucose f18 has been researched along with cgp 48664 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbet, N; Buuren, IV; Capdeville, R; Choi, L; de Vries, EG; Dumez, H; Groen, HJ; Muskiet, F; Oosterom, AT; Paridaens, R; Seeghers, M; Uges, DR; van der Graaf, WT | 1 |
| Aamdal, S; Hersey, P; Joshua, A; Kefford, R; Lynch, K; Millward, MJ; Thomson, D; Toner, G | 1 |
2 trial(s) available for fluorodeoxyglucose f18 and cgp 48664
| Article | Year |
|---|---|
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours.
Topics: Adenosylmethionine Decarboxylase; Adult; Aged; Agranulocytosis; Amidines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Indans; Male; Middle Aged; Neoplasms; Polyamines; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 2000 |
Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma.
Topics: Adenosylmethionine Decarboxylase; Adult; Aged; Amidines; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Indans; Karnofsky Performance Status; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |